Related Experiment Video
Updated: May 10, 2025

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Impact of COVID-19 on Treatment in Patients with Renal Cell Carcinoma
R B Nerli1, S Gautam2, S C Ghagane3
1Department of Urology, JN Medical College, KLE Academy of Higher Education & Research (Deemed-to-be-University), JNMC Campus, Nehru Nagar, Belagavi-590010, Karnataka, India.
Abstract:
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The current pandemic has resulted in a significant reallocation of health-care resources, with the recommended treatment strategy advocating for oncology patients was to delay elective procedures. A retrospective analysis was conducted to evaluatethe impact of COVID-19 on patients with renal cell carcinoma (RCC) and the associated treatment protocols. A retrospective review of the inpatient and outpatient records of all patients presenting with renal cell carcinoma during the period from March 2020 to the end of March 2021 was conducted. A total of 26 patients (21 males and 5 females) with a mean age of 55.46±9.44 years were diagnosed with an operable renal mass during the study period. The mean hospitalisation period (15.19±2.28) was found to be longer in patients who required surgical intervention. The delay was attributable to a number of factors, including the necessity for pre-operative testing using RT-PCR, a chest HR-CT, clearance from the chest physician, and preparation. The overall cost of hospitalization increased in these patients compared to the pre-pandemic period due to a number of factors, including prolonged hospitalization, an increased incidence of complications, the necessity for pre-operative testing for SARS-CoV-2, the use of personal protective equipment, and the provision of nursing care. During the same period, three out of eight patients who had metastatic disease with positive RT-PCR were initiated on targeted therapy, while the remaining underwent cytoreductive nephrectomy. The study concludes that patients with RCC seeking treatment during the current pandemic face significant challenges, including delays in treatment, increased hospitalization rates, and a rise in testing, which collectively contribute to elevated treatment costs. It is imperative to conduct a long-term follow-up to ascertain whether these factors have influenced the outcome of the patients in question.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...

